Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Jun 10:10:888168.
doi: 10.3389/fpubh.2022.888168. eCollection 2022.

Vitamin D: A Potential Mitigation Tool for the Endemic Stage of the COVID-19 Pandemic?

Daniela Briceno Noriega  1 , Huub F J Savelkoul  1
Affiliations
Review

Vitamin D: A Potential Mitigation Tool for the Endemic Stage of the COVID-19 Pandemic?

Daniela Briceno Noriega et al. Front Public Health. .

Abstract

The impact of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic and associated development of clinical symptoms of COVID-19 have presented an enormous global impact on our health care systems, public health and economy. To date several observational epidemiological studies consistently found that vitamin D deficiency, measured as low levels of circulating 25-hydroxyvitamin D, is associated with cardiovascular diseases, diabetes, certain cancers, autoimmune diseases and many infectious diseases, including acute respiratory infections. Since vitamin D is not merely immunosuppressive but also acts as an immunomodulator in tolerance and homeostasis, many experts have considered a role of vitamin D in the prevalence and severity of immune mediated inflammatory diseases, such as SARS-CoV-2, adding to the evidence of the importance of vitamin D in the immune response against viral respiratory infections and reinforcing the need for targeted vitamin D supplementation, with a focus on high-risk populations and a high-dose supplementation treatment for COVID-19 hospitalized patients. The expected transition to endemicity of SARS-CoV-2 even further corroborates as a potential of vitamin D as an potential mitigation tool for the prevention of COVID-19. The aim of this paper is to analyse the current evidence regarding vitamin D and present a hypothesis of its potential role in the current COVID-19 pandemic and in the future as a potential preventive measurement in public health.

Keywords: COVID-19; SARS-CoV-2; endemic; immunomodulation; vitamin D; vitamin D deficiency; vitamin D supplementation.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Vitamin D sources, synthesis and metabolism. CYP27B1, cytochrome P450 Family 27 Subfamily B Member 1; CYP24A1, Cytochrome P450 Family 24 Subfamily A Member 1; VD, vitamin D; VDBP, vitamin D binding protein; VDR, vitamin D receptor; VDRE, vitamin D response element; RXR, retinoid-X receptor.
Figure 2
Figure 2
Vitamin D-dependent Immunomodulation. AMP, antimicrobial peptides; APCs, antigen presenting cells; DC, dendritic cells; Th1, type 1 T helper cells; Th17, type 17 T helper cells; Treg, regulatory T cells.
Figure 3
Figure 3
Vitamin D-dependent Protective vs. Hypovitaminosis D-dependent Detrimental Immune Response against SARS-CoV-2. AMPs, antimicrobial peptides; GM-CSF, granulocyte-macrophage colony-stimulating factor; IL-6, IL-8, IL-17A, interleukin 6, 8 and 17A; IFNγ, interferon-gamma; Th1, Th2, Th17, type 1 T helper cells, type 2 T helper cells, type 17 T helper cells; Th; TNFα, tumor necrosis factor alpha.
Figure 4
Figure 4
Authors recommendations regarding vitamin D research and supplementation.
Figure 5
Figure 5
Forecasting the future for the COVID-19 pandemic, including the possible role for vitamin D supplementation.
Figure 6
Figure 6
Summary of key review points.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Borio LL, Bright RA, Emmanuel EJ. A national strategy for COVID-19 medical countermeasures: vaccines and therapeutics. JAMA. (2022) 327:215–6. 10.1001/jama.2021.24165 - DOI - PubMed
    1. Phillips N. The coronavirus is here to stay – here's what that means. Nature. (2021) 590:382–4. 10.1038/d41586-021-00396-2 - DOI - PubMed
    1. Emmanuel EJ, Osterholm M, Gounder CR. A National Strategy for the “New Normal” of life with COVID. JAMA. (2022) 327:1824. 10.1001/jama.2021.24282 - DOI - PubMed
    1. Garcia-Beltran WF, St Denis KJ, Hoelzemer A, Lam EC, Nitido AD, Sheehan ML, et al. . mRNA-based COVID-19 vaccine booster induce neutralizing immunity against SARS-CoV-2 Omicron variant. Cell. (2022) 185:457–66.e4. 10.1101/2021.12.14.21267755 - DOI - PMC - PubMed
    1. Grant WB, Lahore H, McDonnell SL, Baggerly CA, French CB, Aliano JL, et al. . Evidence that vitamin D supplementation could reduce the risk of Influenza and COVID-19 Infections and Deaths. Nutrients. (2020) 12:988. 10.3390/nu12040988 - DOI - PMC - PubMed